HTG MOLECULAR DIAGNOSTICS, INC Annual Income Tax Expense (Benefit) in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2022.
  • Htg Molecular Diagnostics, Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $2.22K, a 475% increase year-over-year.
  • Htg Molecular Diagnostics, Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $12.7K, a 37.9% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Income Tax Expense (Benefit) for 2022 was $10.8K, a 51.8% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Income Tax Expense (Benefit) for 2021 was $22.5K, a 55.9% increase from 2020.
  • Htg Molecular Diagnostics, Inc annual Income Tax Expense (Benefit) for 2020 was $14.4K, a 327% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $10.8K -$11.6K -51.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $22.5K +$8.06K +55.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $14.4K +$11K +327% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $3.38K -$147 -4.17% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $3.53K +$605 +20.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 $2.92K -$7.2K -71.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $10.1K -$71 -0.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 $10.2K Jan 1, 2015 Dec 31, 2015 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.